Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Product (Monoplace HBOT Devices, Multiplace HBOT Devices, and Topical HBOT Devices), By Application (Decompression Sickness, Wound Healing (Chronic Wounds, Acute Wounds), Infection Treatment, Gas Embolism, Carbon monoxide poisoning and Others), By End User (Hospitals, Ambulatory care centers, Outpatient Clinics, Standalone hyperbaric treatment centers, Homecare, Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends Analysis and Forecast till 2032

[PDF] Hyperbaric Oxygen Therapy Devices are devices that deliver an ideal amount of oxygen to the tissues in the body when the atmosphere is detected to be at a higher pressure. This is a procedure in which the air pressure is raised by two to three times over the normal air pressure and is used to treat blood vessel air bubbles, radiation-related wounds, and various other infections.

The rising prevalence of rates of lifestyle conditions such as diabetes and obesity, rising health-care spending, and the rapidly expanding diagnostic sector are the key factors boosting the growth of the Hyperbaric Oxygen Treatment (HBOT) Devices Market.

For instance, in March 2023, according to NPR (National Public Radio), in a recently published study, over 13,000 participants aged 20 to 44 reported that diabetes and obesity, the two risk factors for heart disease, are increasing among young adults in the U.S.

Furthermore, another study, which was published in the Journal of the American Medical Association, found that obesity increased from 32.7% to 40.9% and that the prevalence of diabetes increased from 3% to 4.1%.

Rising Number of Diabetic Patients to foster the target market growth

The rising number of diabetic patients worldwide has led to a high demand for hyperbaric oxygen therapy devices in the market, which in turn is boosting the growth of the Hyperbaric Oxygen Treatment (HBOT) Devices Market.

For instance, in 2021, according to the International Diabetes Federation, it was reported that around 10.5% of the adult population (20 to 79 years old) had been suffering from diabetes, with almost half of them unaware. Furthermore, it was predicted that by the year 2045, every 1 in 8 adults will be suffering from diabetes; that is an increase of 46%.

Rising Geriatric Population to boost the target market growth

The rise in the geriatric population is one of the key factors leading to the target market's growth. Factors like declining fertility rates and increasing longevity are the reasons why there has been an increase in the geriatric population. Increasing obesity among older people is a critical factor that makes them suffer from serious chronic health disorders like diabetes, eventually leading to the growth of the Hyperbaric Oxygen Treatment (HBOT) Devices Market.

 Restrains:

The High Cost associated with these devices and setups is the major factor restraining the growth of the Hyperbaric Oxygen Treatment (HBOT) Devices Market. For instance, according to Relias Media, it was reported that at Sechrist Industries (a wound healing service provider in Anaheim, CA), the price of a single-person (monoplace) hyperbaric chamber ranges from $94,000 to $135,000. The price of multi-place chambers might reach $800,000.

Hyperbaric Oxygen Therapy (HBOT) Devices Market is segmented based on Product, Application, End User and Region.

Product Insight

On the basis of Product, Hyperbaric Oxygen Therapy (HBOT) Devices Market is segmented into Monoplace HBOT Devices, Multiplace HBOT Devices, and Topical HBOT Devices. The Monoplace HBOT Devices product segment is expected to dominate the growth of the target market owing to the fact that they are less confining and more comfortable compared to the multiplace HBOT devices.

Application Insights

On the basis of Application, Hyperbaric Oxygen Therapy (HBOT) Devices Market is segmented into Decompression Sickness, Wound Healing (Chronic Wounds, Acute Wounds), Infection Treatment, Gas Embolism, Carbon monoxide poisoning and others. The Wound Healing application segment is expected to dominate the growth of the target market owing to the rising prevalence of wounds and effective treatments for chronic wounds.

End-Users Insights

On the basis of End-User, Hyperbaric Oxygen Therapy (HBOT) Devices Market is segmented into Hospitals, Ambulatory care centers, Outpatient Clinics, Standalone hyperbaric treatment centers, Homecare, Others. The Home Care end-user segment is expected to dominate the growth of the target market owing to the rising demand for personalized healthcare.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On the basis of Region, the Hyperbaric Oxygen Therapy (HBOT) Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the target market in the near future, owing to their advancements in technology in hyperbaric oxygen therapy techniques, incorporation of advanced devices, improved healthcare facilities as well as research and development programs. 

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Hyperbaric Oxygen Therapy (HBOT) Devices Market report based on Product, Application, End Users and Region:

Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Product:

• Monoplace HBOT Devices
• Multiplace HBOT Devices
• Topical HBOT Devices

Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Application:

• Decompression Sickness
• Wound Healing (Chronic Wounds, Acute Wounds)
• Infection Treatment
• Gas Embolism
• Carbon monoxide Poisoning
• Others

Hyperbaric Oxygen Therapy (HBOT) Devices Market, By End-Users:

• Hospitals
• Ambulatory Care Centers
• Outpatient Clinics
• Standalone Hyperbaric Treatment Centers
• Homecare
• Others

Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the Hyperbaric Oxygen Therapy (HBOT) Devices Market includes, Perry Baromedical Corporation, Sechrist Industries, Inc., Environmental Tectonics Corporation, HAUX-LIFE-SUPPORT GmbH, IHC Hytech B.V., OxyHeal International, Inc., Fink Engineering, Hyperbaric SAC, Hearmec Co., Ltd., and ETC Biomedical Systems.

• Perry Baromedical Corporation*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Sechrist Industries, Inc.
• Environmental Tectonics Corporation
• HAUX-LIFE-SUPPORT GmbH
• IHC Hytech B.V.
• OxyHeal International, Inc.
• Fink Engineering
• Hyperbaric SAC
• Hearmec Co., Ltd.
• ETC Biomedical Systems

“*” marked represents similar segmentation in other categories in the respective section

Recent Development:

• In November 2019, AHA Hyperbarics launched their product, "AHA Flex V2", which is a new model of the high-pressure medical hyperbaric chambers that were made specifically to fulfil the rising need for HBOT safety and efficacy.
• In July 2019, an advanced subsea, offshore, and life support solution provider company, Unique Group, launched "The Uni-Heal 2200 hyperbaric oxygen treatment facility", its next generation multi-place hyperbaric oxygen treatment chamber.
• In July 2018, a well-known company, Perry Baromedical and Kent Imaging Inc., formed a strategic agreement in the field of hyperbaric medicine under which Perry Baromedical would market Kent's KD203, a near-infrared imaging equipment. "Sigma 40-II", a hyperbaric oxygen treatment (HBOT) device with the biggest 2-person chamber, was introduced to the market by Perry Baromedical.